A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: unbiased (1), impartial (11), pale (37)

Eribulin

Description
Chemotherapy Protocol BREAST CANCER ERIBULIN Regimen • Breast Cancer – Eribulin Indication • Treatment of locally advanced or metastatic breast cancer which has progressed aft
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastEribulinVer1.2.pdf

Cyclophosphamide-Epirubicin Ver 1.1

Description
Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN Regimen Breast Cancer – Cyclophosphamide-Epirubicin Indication Primary systemic (neoadj
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Cyclophosphamide-Epirubicin-Ver-11.pdf

Cyclophosphamide-Doxorubicin Ver 1.1

Description
Regimen Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOXORUBICIN Breast Cancer – Cyclophosphamide-Doxorubicin Indication Primary systemic (neoadjuvant) therapy of breast
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Cyclophosphamide-Doxorubicin-Ver-1.1.pdf

Cytarabine3000

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA CYTARABINE (3000mg/m2) In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Cytarabine (3000mg/m2) In
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Cytarabine3000.pdf

AmsacrineCytarabineEtoposide_MACE

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA AMSACRINE-CYTARABINE-ETOPOSIDE In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Amsacrine-Cytarabine-Etoposide (MACE)
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/AmsacrineCytarabineEtoposide-MACE.pdf

Gemcitabine ver1

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER GEMCITABINE Regimen Ovarian – Gemcitabine Indication The treatment of advanced ovarian cancer WHO Performance status 0, 1, 2 Toxici
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Gemcitabine-ver1.pdf

Panitumumab (21 day) Ver 1.1

Description
Chemotherapy Protocol COLORECTAL CANCER PANITUMUMAB (21 day) This regimen may require funding and is an unlicensed dose Regimen Colorectal Cancer – Panitumumab (21
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Panitumumab21dayVer11.pdf

Justifying termination of pregnancy

Description
The court considers whether termination of pregnancy is in the best interests of a young woman who lacks capacity.
Url
/HealthProfessionals/Clinical-law-updates/Justifying-termination-of-pregnancy.aspx

InP-Etoposide-Ifosfamide (3 day) v2

Description
Chemotherapy Protocol SARCOMA ETOPOSIDE-IFOSFAMIDE (3 day) Inpatient Regimen Regimen • Sarcoma-InP-Etoposide-Ifosfamide (3 day) Indication • Second line treatment of osteos
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InP-Etoposide-Ifosfamide-3-day-v2.pdf

Gemcitabine-Paclitaxel Albumin Bound (Abraxane)

Description
Chemotherapy Protocol PANCREATIC CANCER GEMCITABINE-PACLITAXEL ALBUMIN BOUND Regimen • Pancreatic Cancer – Gemcitabine-Paclitaxel Albumin Bound Indication • First line treatme
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Pancreas/Gemcitabine-Paclitaxel-Albumin-Bound-Abraxane-Ver2.pdf
91 to 100 of 265
Previous … 8 9 10 11 12 … Next